Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by inventorson Apr 07, 2011 11:17pm
328 Views
Post# 18402666

T.PLI - Verbatim Fur-balls

T.PLI - Verbatim Fur-ballsMy take on the cc,

PL seemed to shy away from further details on more contracts, but he said there is more coming.

The 10 M deal is to protect Celegene the way PLI needed protection from Hemosol, two years ago, lol?

Looking forward, lets see if volume picks up, and if the sp will close tomorrow at 0.235, now that would be nice.

Q1 should be interesting to see if PLI can deliver 3-6M in revenue, but PL stated the new building would carry up to 6 M is operational costs for the year. I think PLI will provide a positive EBITA for the Q1.

At least one more contract, a new name for NewCo, and financing at much higher level is what I'm forecasting, before Q1 financals come out, or by the AGM, lol?

Yes, I said financing, sorry, but liquidity is important when you are a public company.

Perhaps it will be a shelf perspectus with NewCo, and what would that do to the sp?

I must commend PL in trying to keep his loose lips from spilling any new beans, but it is true, in that most parterships are based on private affairs, not to be discussed in public. Very confidential is a must, lol?

Investors will be looking closely on the next 18 months revenue forecasts, and this time I think PLI is in the right place, space, and time. Much better balanced sheet, near term orders, and a heathy backlog of partnership that should really start to kick in by years out. PL did say the H2 will be stronger
Bullboard Posts